Roly
Good point about Cf33. I do hope it has terrific result and blows Hervaxx in terms of success for patients and shareholder value. Point being we have so many trials with possible really good results. Yes its all speculative but not half as speculative as it was . When Hervaxx was pre stage 2 trials IMU was less than 10 cents but with so much value added now the possibilities are more and the potential benefits are more. I think the upside is more IMHO.
I see no reason to exit at this point and I will get better at looking up the trial sites data rather than wait for ASX updates.
GLTA shareholders.
Prediction, page-25
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $327.2M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.6¢ | 4.4¢ | $358.2K | 7.968M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 3601437 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 671952 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |